Heregulin-Induced Growth Factor Receptor Signaling and Breast Carcinogenesis.

Abstract

We are studying how the signaling network composed of the Epidermal Growth Factor (EGF) family of peptide hormones and the ErbB family of receptor tyrosine kinases is differentially activated and coupled to physiologic responses. Because deregulation of this signaling network plays a significant role in the genesis or progression of several different human metastatic diseases, an understanding of the basic 'wiring' of this network is required to elucidate the mechanisms of these diseases. We have generated a panel of cell lines based on the Interleukin-3 (IL3) -dependent Ba/F3 mouse hematopoietic cell line that ectopically express the four ErbB family receptors. We have then identified the patterns of ErbB family receptor phosphorylation and IL3-independent responses stimulated by different EGF family hormones. We will present data supporting several concepts that have emerged from these studies: (1) Differential Activation by EGF Family Hormones. EGF family hormones can be assigned to three distinct functional groups based on their stimulation of ErbB family receptor phosphorylation. (2) Differential Coupling by ErbB Family Receptors. ErbB family receptors and combinations of receptors differentially couple to IL3-independent responses in Ba/F3 cells. Furthermore, ErbB family receptors directly activated by ligand binding behave differently from receptors activated in trans through receptor heterodimerization.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 1997
Accession Number
ADA331278

Entities

People

  • David F. Stern
  • David J. Riese

Organizations

  • Yale University

Tags

DTIC Thesaurus Topics

  • Breast Cancer
  • Cell Line
  • Cells
  • Chemistry
  • Cultured Cells
  • Epithelial Cells
  • Growth Factors
  • Health Services
  • Mammary Glands
  • Medical Personnel
  • Peptide Growth Factors
  • Peptides
  • Proteins

Fields of Study

  • Biology
  • Medicine

Readers

  • Breast cancer cell signaling and growth regulation.